Cargando…
Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint Inhibitors
Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer‐related deaths in China. The recent emergence of immunotherapy treatment options, such as the use of programmed cell death protein 1 (PD‐1)/programmed death‐ligand 1 (PD‐L1) checkpoint inhibitors, has also led to a par...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394773/ https://www.ncbi.nlm.nih.gov/pubmed/30819828 http://dx.doi.org/10.1634/theoncologist.2019-IO-S1-s02 |